PROCUREMENT OF ANTHRAX VACC AND BOTULINUM TOXOID PENTAVALENT

File: 110596_sep96_decls13_0001.txt
Page: 0001
Total Pages: 1

Subject: PROCUREMENT OF ANTHRAX VACC AND BOTULINUM TOXOID PENTAVALENT    

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003201

Folder Title: PROCUREMENT OF ANTHRAX VACCINE AND BOTULINUM                                                    

Document Number:          1

Folder SEQ  #:         87



                                   icrf%nrt
                                   I@LVI@ UNCLASSIFIED

                               DEPAFRTMENT OF THE ARMY
                               OFFICE OF THE SURGEON GENERAL
                                   5109 LEESBURG PIKE
                                FALLS CHURCH, VA 22041-3258
              REPLY TO
              A@ENTION OF


         DASG-HCD-D   (50k)                                      9 SEP 1990

         MEMORANDUM FOR COMMANDER, U.S. ARMY MEDICAL RESEARCH AND
                          DEVELOPMENT COMMAND, ATTN: SGRD-ZA, FORT DETRICK,
                          FREDERICK, MD 21701-5012

         SUBJECT: Procurement of Anthrax Vaccine and Botulinum Toxoid,
         Pentavalent (U)


         1. @ U.S. Army Medical Research and Development Command
         (USAMRDC) should initiate immediate procurement of
         anthrax vaccine for the Biological Warfare Contingency szockpile
         using FY90 funds already provided. Estimated cost of
               of anthrax vaccine is $2.4M. The contract should include an
        "ti=c)n to procure additional doses of vaccine.

         2. @ USAMPDC should also initiate procurement for a second batch
                          pentavalent botulinum toxoid for the Biological
         Warfare Contingency Stockpile. Award of the contract does not have
         to occur until latter part of FY91 because production of the first
         batch                  toxoid is already scheduled as stipulated by
         a contract awarded in FY89. Estimated cost of the second batch of
                           oxoid doses is $7.5M. Also, ensure that an
         option is provided in the contract to permit procurement of
         additional doses of pentavalent botulinum toxoid.

         3.       If the decision is made to vaccinate the total U.S. force
         in the AOR, the Biological Warfare Defense Ad Hoc Committee
         recommended that a total of 621@--'T&!" anthrax and
                    e
         botulinum toxoid be procured. Tnis is in addition to          6
         anthrax vaccine and FY89 botulinum toxoid procurements.

         4. (U) Point of contact for this action is MAJ Robert Eng,
         DASG-HCD-D, AUTOVON 289-8163 or (703) 756-8163.

         FOR THE SURGEON GENERAL:





        DECLASSIFIED
        ON: 29 OCT 96                   Director, Health care operations
        BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO 12958

         CLASSIFIED BY: DIR, HEALTH CARE OPERATIONS
         DECLASSIFY ON: OADR


                                             UNCLASSIFIED

Document 1 f:/Week-36/BX003201/PROCUREMENT OF ANTHRAX VACCINE AND BOTULINUM/procurement of anthrax vacc and botulinum toxoid:11049609101414
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = PROCUREMENT OF ANTHRAX VACCINE AND BOTULINUM
Folder Seq # = 87
Subject = PROCUREMENT OF ANTHRAX VACC AND BOTULINUM TOXOID
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 04-NOV-1996